We are live on ! Find out more
KURA icon

Kura Oncology
KURA

44 hedge funds and large institutions have $101M invested in Kura Oncology in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

26% more funds holding

Funds holding: 35 → 44 (+9)

11% more capital invested

Capital invested by funds: $90.7M → $101M (+$9.83M)

2.3% more ownership

Funds ownership: 48.2% → 50.51% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
44
Holders Change
+9
Holders Change %
+25.71%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
13
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$5.06M
2
State Street
State Street
Massachusetts
+$1.36M
3
Morgan Stanley
Morgan Stanley
New York
+$1.29M
4
Northern Trust
Northern Trust
Illinois
+$1.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$455K

Top Sellers

1
EC
EcoR1 Capital
California
-$5.26M
2
CCP
Clough Capital Partners
Massachusetts
-$726K
3
Goldman Sachs
Goldman Sachs
New York
-$533K
4
Millennium Management
Millennium Management
New York
-$355K
5
Squarepoint
Squarepoint
New York
-$196K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$26.2M – – –
PHS
2
PFM Health Sciences
California
$18.9M +$38.8K +4,264 +0.2%
EC
3
EcoR1 Capital
California
$18.9M -$5.26M -578,284 -22%
BlackRock
4
BlackRock
New York
$5.53M +$5.06M +555,938 +1,427%
Morgan Stanley
5
Morgan Stanley
New York
$5.32M +$1.29M +141,795 +33%
BC
6
Boxer Capital
California
$4.96M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$4.04M +$455K +50,033 +13%
CCP
8
Clough Capital Partners
Massachusetts
$3.92M -$726K -79,700 -16%
MA
9
Minerva Advisors
Pennsylvania
$2.68M -$67.4K -7,400 -2%
State Street
10
State Street
Massachusetts
$1.39M +$1.36M +149,749 New
Northern Trust
11
Northern Trust
Illinois
$1.37M +$1.21M +133,293 +939%
ACM
12
Alethea Capital Management
Washington
$899K +$108K +11,904 +14%
BCM
13
Bridgeway Capital Management
Texas
$860K +$2.28K +250 +0.3%
Renaissance Technologies
14
Renaissance Technologies
New York
$837K +$98.3K +10,800 +14%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$678K +$212K +23,237 +47%
Deutsche Bank
16
Deutsche Bank
Germany
$472K +$236K +25,974 +104%
TCIM
17
TIAA CREF Investment Management
New York
$385K +$377K +41,402 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$291K +$284K +31,250 New
PPCM
19
Pillar Pacific Capital Management
California
$284K – – –
JMPWA
20
JP Morgan Private Wealth Advisors
California
$274K – – –
TA
21
Teachers Advisors
New York
$256K +$250K +27,505 New
NFA
22
Nationwide Fund Advisors
Ohio
$240K +$93.4K +10,258 +66%
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$235K +$230K +25,300 New
Charles Schwab
24
Charles Schwab
California
$226K +$221K +24,300 New
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$219K – – –
1
2 3

KURA Hedge Fund Activity: Q2 2017 in Review

44 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2017, worth a combined $101M — up 11% from $90.7M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $5.06M. The largest seller was EcoR1 Capital, cutting an estimated $5.26M.

  • 44 institutional investors held Kura Oncology (KURA) as of Q2 2017, up from 35 in Q1 2017.
  • Funds reported $101M of Kura Oncology stock for Q2 2017, up 11% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q2 2017 and 10 closed out, a net change of +9 holders.
  • The largest Kura Oncology buyer in Q2 2017 was BlackRock, an estimated $5.06M added.
  • The largest Kura Oncology seller in Q2 2017 was EcoR1 Capital, an estimated $5.26M sold.

Based on aggregated 13F filings for Q2 2017.